Clinical Trials for Drug: JX-594

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-15-80 A Phase 3 Randomized, Open-Label Study Comparing Pexa-Vec (Vaccinia GM-CSF /Thymidine Kinase-Deactivated Virus) Followed by Sorafenib Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC) Without Prior Systemic Therapy Open